The global medical packaging films market is expanding steadily as pharmaceutical and medical device manufacturers seek high-barrier, sterile packaging solutions capable of meeting stringent regulatory standards while advancing sustainability goals. New research values the market at USD 10.68 billion in 2023, with growth expected to carry it from USD 11.21 billion in 2024 to USD 16.83 billion by 2031, reflecting a compound annual growth rate of 5.98% over the forecast period.

Medical packaging films — engineered from materials such as polyethylene, polypropylene, PVC, and multi-layer laminates — safeguard pharmaceuticals and medical devices from moisture, oxygen, light, and contaminants while preserving sterility during storage and transport. Demand for these specialized materials is closely tied to the continued expansion of the global pharmaceutical and healthcare industries.

Healthcare Spending Growth Underpins Packaging Demand

Rising global healthcare expenditure is a foundational driver of market expansion. A 2024 report from the U.S. Centers for Medicare & Medicaid Services found that national healthcare spending climbed 7.5% in 2023 to total USD 4.9 trillion — equivalent to USD 14,570 per person and 17.6% of U.S. GDP. As pharmaceutical production scales in tandem with this spending, particularly for biopharmaceuticals, vaccines, and other temperature-sensitive biologics, demand for advanced barrier films that preserve drug efficacy and extend shelf life continues to intensify.

Sustainability Initiatives Reshape Material Selection

Sustainability has emerged as a defining driver in the sector, with manufacturers shifting toward recyclable, biodegradable, and low-carbon-footprint materials to align with regulatory expectations and corporate environmental commitments. Advances in bio-based polymers, solvent-free coatings, and energy-efficient manufacturing are enabling this transition without compromising the sterility and performance standards required in medical applications.

Illustrating this shift, French ophthalmology laboratory Horus Pharma expanded its partnership with Plastic Bank in April 2024 to reduce its plastic footprint in the Mediterranean, targeting an offset of 65% of its plastic distribution and recycling of 400 metric tons of plastic between late 2022 and late 2025. Similarly, Sanofi Consumer Healthcare joined the Blister Pack Collective in February 2024, an initiative led by PA Consulting and PulPac to develop recyclable fiber-based blister packs using Dry Molded Fiber technology, targeting an 80% lower carbon footprint than conventional materials.

Supply Chain Disruptions Test Manufacturer Resilience

Raw material fluctuations, shipping delays, and cost volatility continue to pose challenges for medical packaging film producers, potentially disrupting production schedules and elevating operational costs. In response, companies are investing in advanced supply chain management systems, diversifying supplier networks, and adopting digital monitoring tools that enable real-time forecasting and faster responses to potential disruptions.

Rising Surgical Volumes Fuel Sterile Packaging Demand

The growing frequency of surgical procedures and hospitalizations is a significant trend shaping demand. The American Society of Plastic Surgeons reported that 26.2 billion surgical and minimally invasive cosmetic and reconstructive procedures were performed in the United States, with cosmetic procedures rising 19% compared to pre-pandemic levels. The broader shift toward minimally invasive surgery is increasing reliance on disposable medical devices, driving demand for high-performance films used in IV bags, blood bags, and diagnostic kits.

Segment Insights: High Barrier Films and Polyethylene Lead

By type, high barrier films represented the largest segment in 2023, generating USD 3.93 billion in revenue, owing to superior protective properties that ensure sterility and extend shelf life while meeting stringent regulatory requirements. By material, polyethylene held a 28.45% market share, favored for its durability, cost-effectiveness, and compatibility with sterilization processes. By application, bags and pouches are projected to reach USD 5.17 billion by 2031, reflecting their widespread use in cost-effective, high-barrier sterile packaging. By end-use, medical devices are expected to grow at a CAGR of 5.99%, driven by rising global production and adoption of medical devices requiring compliant, sterile packaging.

North America Leads on Regulatory Rigor; Asia Pacific Set for Fastest Growth

North America held the largest regional share in 2023 at 35.29%, valued at USD 3.77 billion, driven by a stringent regulatory environment overseen by the FDA, Health Canada, and the United States Pharmacopeia, all of which enforce strict standards around tamper resistance, barrier protection, and sustainability. Companies including Berry Global Inc. are actively partnering with healthcare institutions on recycling initiatives; in July 2023, the company partnered with Deaconess Midtown Hospital, Nexus Circular, and Evansville Packaging Supply to recycle non-hazardous sterile plastic packaging from hospital operations.

Asia Pacific is projected to register the fastest regional growth at a CAGR of 6.60%, reaching USD 4.27 billion by 2031, propelled by the region’s expanding role as a global pharmaceutical manufacturing hub. China, India, and Japan lead in drug production and exports, while rising demand for diagnostic kits, surgical instruments, and home diagnostics is accelerating the need for high-quality, flexible medical packaging films across the region.

Regulatory Landscape Shapes Product Development

Compliance requirements remain central to competitive positioning across regions. In the U.S., the FDA’s Quality System Regulation under 21 CFR Part 820 governs packaging design and manufacturing. The European Medicines Agency enforces Good Manufacturing Practice guidelines, while China’s National Medical Products Administration and India’s Central Drugs Standard Control Organization impose their own rigorous testing and approval requirements for new packaging materials.

Competitive Landscape

Major companies operating in the market include Amcor plc, Berry Global, Inc., Klöckner Pentaplast, UFP Technologies, Inc., Gerresheimer AG, Avery Dennison Corporation, SIG Combibloc Group AG, Bemis Company, Inc., Sealed Air Corporation, Wipak Oy, AptarGroup, Inc., Sonoco Products Company, Tekni-Plex, Inc., Placon Corporation, and Printpack, Inc. In November 2024, Amcor introduced its next-generation Medical Laminates solution, enabling fully recyclable all-film packaging within the polyethylene stream. That same month, Berry Global completed a merger of its nonwovens and films business with Glatfelter Corporation, forming Magnera Corporation — now the world’s largest nonwovens company. In February 2025, Berry Global also expanded its Bontite Sustane Stretch Film portfolio to incorporate 30% certified post-consumer recycled content.

Outlook

As pharmaceutical production scales globally and sustainability regulations tighten, the medical packaging films market is set for continued growth through 2031. Manufacturers that can deliver recyclable, high-barrier solutions without compromising regulatory compliance or sterility will be best positioned to capture emerging opportunities across both mature and high-growth markets.